phloretic acid has been researched along with Disbacteriosis in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 3 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bassermann, F; Fan, K; Göttert, S; Heidegger, S; Heinrich, P; Herr, W; Joachim, L; Kleigrewe, K; Neuhaus, K; Orberg, ET; Poeck, H; Posch, C; Ruland, J; Sax, A; Steiger, K | 1 |
| Gao, J; Kou, Y; Liang, M; Liu, M; Liu, Z; Meng, L; Sun, H; Wang, Y; Wei, Y; Xu, S; Zheng, X | 1 |
| Cai, Y; Li, F; Luo, Y; Shi, X; Wang, L | 1 |
3 other study(ies) available for phloretic acid and Disbacteriosis
| Article | Year |
|---|---|
The microbial metabolite desaminotyrosine enhances T-cell priming and cancer immunotherapy with immune checkpoint inhibitors.
Topics: Animals; Anti-Bacterial Agents; Dysbiosis; Humans; Immune Checkpoint Inhibitors; Immunotherapy; Melanoma; Mice; T-Lymphocytes; Tumor Microenvironment | 2023 |
The intestinal microbial metabolite desaminotyrosine is an anti-inflammatory molecule that modulates local and systemic immune homeostasis.
Topics: Animals; Anti-Inflammatory Agents; Diet, High-Fat; Dysbiosis; Endotoxemia; Flavonoids; Gastrointestinal Microbiome; Homeostasis; Immunity; Inflammation; Intestines; Male; Mice; Phenylpropionates; Shock, Septic | 2020 |
Safety assessment of desaminotyrosine: Acute, subchronic oral toxicity, and its effects on intestinal microbiota in rats.
Topics: Administration, Oral; Animals; Bacteria; Biomarkers; Blood Glucose; Dose-Response Relationship, Drug; Dysbiosis; Eating; Female; Gastrointestinal Microbiome; Kidney; Lethal Dose 50; Liver; Lung; Male; No-Observed-Adverse-Effect Level; Phenylpropionates; Rats, Sprague-Dawley; Risk Assessment; Toxicity Tests, Subchronic; Weight Gain | 2021 |